Patents by Inventor Ivar SJAASTAD

Ivar SJAASTAD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10744155
    Abstract: The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: August 18, 2020
    Assignee: UNIVERSITETET I OSLO
    Inventors: Maria Vistnes, Geir Christensen, Magnus Aronsen, Ida Gjervold Lunde, Ivar Sjaastad, Cathrine Rein Carlson
  • Publication number: 20190282606
    Abstract: The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure.
    Type: Application
    Filed: May 6, 2019
    Publication date: September 19, 2019
    Applicant: Universitetet i Oslo
    Inventors: Maria VISTNES, Geir CHRISTENSEN, Magnus ARONSEN, Ida Gjervold LUNDE, Ivar SJAASTAD, Cathrine Rein CARLSON
  • Patent number: 10322143
    Abstract: The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: June 18, 2019
    Assignee: UNIVERSITETET I OSLO
    Inventors: Maria Vistnes, Geir Christensen, Magnus Aronsen, Ida Gjervold Lunde, Ivar Sjaastad, Cathrine Rein Carlson
  • Publication number: 20160158271
    Abstract: The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 9, 2016
    Applicant: Universitetet i Oslo
    Inventors: Maria VISTNES, Geir CHRISTENSEN, Magnus ARONSEN, Ida Gjervold LUNDE, Ivar SJAASTAD, Cathrine Rein CARLSON